Healthcare Economist January 17, 2025
Jason Shafrin

From the CMS document “Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price
Applicability Year 2027
“:

On January 17, 2025, CMS announced the selection of the below list of 15 drugs covered under Medicare Part D for the second cycle of negotiations (initial price applicability year 2027), based on total gross covered prescription drug costs under Medicare Part D and other criteria as required by the law.

With the Trump inauguration to take place on Monday, will the Medicare Drug Price Negotiation process change...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Health Equity: Why It’s Vital to Star Ratings Performance
Medicare reimbursement rates explained: Why they keep declining, and what the future holds
Podcast: What's Happening with Value-Based Insurance Design? w/ Mark Fendrick
CMS cuts funding to ACA Navigator program
Medicare Drug Coverage Is Often Inadequate—Here’s Why

Share This Article